Fair Value Measurements - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Schedule of Equity Method Investments [Line Items]
Impairment of investment in private companies	$ 0	$ 30,321	$ 2,575
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	9,300	1,200
Strategic investments	3,710	6,527
Series A Preferred Stock [Member] | Lacerta Therapeutics Inc [Member]
Schedule of Equity Method Investments [Line Items]
Impairment of investment in private companies		30,000
Fair Value, Inputs, Level 3 [Member]
Schedule of Equity Method Investments [Line Items]
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	$ 9,500	2,000
Other Noncurrent Assets [Member]
Schedule of Equity Method Investments [Line Items]
Strategic investments		$ 2,700